Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
150 hedge funds and large institutions have $1.18B invested in Translate Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 21 closing their positions.
86% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 21
27% more capital invested
Capital invested by funds: $936M → $1.18B (+$249M)
16% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 44
14% more funds holding
Funds holding: 132 → 150 (+18)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
80% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $10.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$34.5M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.17M |
| 3 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$6.98M |
| 4 |
Barclays
London,
United Kingdom
|
+$2.87M |
| 5 |
BlackRock
New York
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$35.2M |
| 2 |
AVA
Atlas Venture Advisors
Boston,
Massachusetts
|
-$21.1M |
| 3 |
Goldman Sachs
New York
|
-$15M |
| 4 |
RI
RTW Investments
New York
|
-$13.7M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$12.8M |
TBIO Hedge Fund Activity: Q4 2020 in Review
150 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2020, worth a combined $1.18B — up 27% from $936M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new TBIO positions and 21 closed out — a net gain of 18 holders — while 51 added to existing stakes and 44 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $34.5M. The largest seller was State Street, cutting an estimated $35.2M.
- 150 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2020, up from 132 in Q3 2020.
- Funds reported $1.18B of Translate Bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
- 39 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2020 and 21 closed out, a net change of +18 holders.
- The largest Translate Bio, Inc. Common Stock buyer in Q4 2020 was Invesco, an estimated $34.5M added.
- The largest Translate Bio, Inc. Common Stock seller in Q4 2020 was State Street, an estimated $35.2M sold.
Based on aggregated 13F filings for Q4 2020.